Neurocrine Biosciences Inc (NASDAQ:NBIX)

42.55
Delayed Data
As of May 22
 +0.57 / +1.36%
Today’s Change
12.63
Today|||52-Week Range
45.36
+90.47%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close41.98
Today’s open42.90
Day’s range41.98 - 43.67
Volume1,276,876
Average volume (3 months)1,005,909
Market cap$3.6B
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)-6.17%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book15.59

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+0.75+1.65%
ACADACADIA Pharmaceutica...+0.33+0.82%
CLVSClovis Oncology Inc+0.23+0.25%
WXWuXi PharmaTech (Cay...-0.13-0.30%
Data as of 4:02pm ET, 05/22/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$60.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers